Topicals for Psoriasis: Classical Drugs, New Concepts, and New Medications
- 1 June 2026
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 53 (Suppl 2) , 12-14
Abstract
Psoriasis is a chronic, immune-mediated disease affecting the skin. Its prevalence varies by region (0.2-9%), and some patients may develop joint involvement. For mild disease, and as adjuncts in moderate disease, topical therapies remain the foundation of care. Classical agents include topical corticosteroids and vitamin D analogs. Other legacy options (tazarotene, salicylic acid, coal tar, and calcineurin inhibitors) serve as adjuvants with variable efficacy. Recent advances have led to new targeted nonsteroidal topicals such as tapinarof (aryl hydrocarbon receptor agonist) and roflumilast (phosphodiesterase 4 inhibitor). We summarize evidence, propose practical prescribing recommendations for nondermatologists, and position new agents within a steroid-sparing, precision framework. A persistent challenge is affordability, in which high acquisition costs for novel topicals may restrict real-world access unless supported by pricing and reimbursement policies. This work was presented at the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2025 annual meeting in Bogotá as a concurrent session.Keywords
This publication has 18 references indexed in Scilit:
- Treatment satisfaction of patients with psoriasis with topical therapy in a real-world setting: unmet need for higher effectivenessJournal of Dermatological Treatment, 2023
- Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque PsoriasisJAMA, 2022
- Prevalencia de psoriasis en Colombia según datos del Registro Nacional en SaludActas Dermo-Sifiliograficas, 2022
- Pathophysiology of Generalized Pustular PsoriasisAmerican Journal of Clinical Dermatology, 2022
- Phase 3 Trials of Tapinarof Cream for Plaque PsoriasisNew England Journal of Medicine, 2021
- Psoriasis patient preferences for topical drugs: a systematic reviewJournal of Dermatological Treatment, 2019
- Recommandations françaises sur l’utilisation des traitements systémiques chez les patients adultes atteints de psoriasis modéré à sévèreAnnales de Dermatologie et de Vénéréologie, 2019
- Topical treatments for chronic plaque psoriasis: An abridged Cochrane Systematic ReviewJournal of the American Academy of Dermatology, 2013
- Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analysesBritish Journal of Dermatology, 2013
- Global Epidemiology of Psoriasis: A Systematic Review of Incidence and PrevalenceJournal of Investigative Dermatology, 2013